Updated Results from a Phase I/II Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Richter's Syndrome (RS)
Ryan, Christine E., Crombie, Jennifer L., Tyekucheva, Svitlana, McDonough, Mikaela M., Montegaard, Josie S., Kim, Austin I., Soumerai, Jacob D., Alencar, Alvaro J., Bhandari, Shruti, Fisher, David C., Brown, Jennifer R., Davids, Matthew S.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Updated Results from a Multicenter, Phase 2 Study of Acalabrutinib, Venetoclax, Obinutuzumab (AVO) in a Population of Previously Untreated Patients with CLL Enriched for High-Risk Disease
Ryan, Christine E., Lampson, Benjamin L., Tyekucheva, Svitlana, Hackett, Liam R., Ren, Yue, Shupe, Samantha J., Fernandes, Stacey M., Crombie, Jennifer L., Ng, Samuel, Kim, Austin I., Ahn, Inhye E., Weinstock, Matthew J, Pazienza, Samantha, Montegaard, Josie S., Patterson, Victoria, Jacobson, Caron A., LaCasce, Ann S., Armand, Philippe, Fisher, David C., Arnason, Jon E., Lo, Steve, Olszewski, Adam, Brown, Jennifer R., Davids, Matthew S.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article